Drug
Combined epidural-general anesthesia
Combined epidural-general anesthesia is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery
NCT02801409
completednot_applicable
Epidural Anesthesia-analgesia and Long-term Outcome
NCT03012945
completednot_applicable
Epidural Anesthesia and Long-term Outcomes in Elderly Patients After Surgery
NCT03335826
Clinical Trials (3)
Showing 3 of 3 trials
NCT02801409Not Applicable
Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery
NCT03012945Not Applicable
Epidural Anesthesia-analgesia and Long-term Outcome
NCT03335826Not Applicable
Epidural Anesthesia and Long-term Outcomes in Elderly Patients After Surgery
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3